Thalidomide Downregulates Angiogenic Genes in Bone Marrow Endothelial Cells of Patients With Active Multiple Myeloma

2005131 citationsJournal Articlebronze Open Access

Authors

Inhibition by thalidomide is probably confined to the genes of active MMECs and KS. This would account for its higher efficacy in these diseases.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 23, Issue 23, pp. 5334-5346

Field-Weighted Citation Impact: 6.92